Chimeric antigen receptor specifically binding to CD 300c antigen or receptor thereof
The present invention relates to a chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof, and immune cells expressing same, or the like. The chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof according to the present invention...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JEON, Jaewon KIM, Haneul LEE, Suin |
| description | The present invention relates to a chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof, and immune cells expressing same, or the like. The chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof according to the present invention specifically recognizes cancer cells expressing a CD300c antigen or CD300c receptor and directly effectively inhibits the growth of cancer, metastasis, or the like, and moreover, activates T cells and the like in the body through the inhibition of CD300c, and thereby can reduce side effects and also increase a cancer therapeutic effect, and thus is expected to be effectively used as an immunotherapeutic agent for various cancers. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020394279A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020394279A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020394279A13</originalsourceid><addsrcrecordid>eNqNy7EKwjAURuEsDqK-w4XOQkwE6Vii4gPYucT4t70Qk5Bk8e11EF2dzvKdpejNzA9kdmRD5QmBMhxSjZlKguORnfX-STcOdw4T1UjmSFrK3_Cm36fOyIjjWixG6ws2n65Ecz5dzWWLFAeUZB0C6tD1Siqp2706tN1O_6deWLM5MQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chimeric antigen receptor specifically binding to CD 300c antigen or receptor thereof</title><source>esp@cenet</source><creator>JEON, Jaewon ; KIM, Haneul ; LEE, Suin</creator><creatorcontrib>JEON, Jaewon ; KIM, Haneul ; LEE, Suin</creatorcontrib><description>The present invention relates to a chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof, and immune cells expressing same, or the like. The chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof according to the present invention specifically recognizes cancer cells expressing a CD300c antigen or CD300c receptor and directly effectively inhibits the growth of cancer, metastasis, or the like, and moreover, activates T cells and the like in the body through the inhibition of CD300c, and thereby can reduce side effects and also increase a cancer therapeutic effect, and thus is expected to be effectively used as an immunotherapeutic agent for various cancers.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220616&DB=EPODOC&CC=AU&NR=2020394279A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220616&DB=EPODOC&CC=AU&NR=2020394279A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JEON, Jaewon</creatorcontrib><creatorcontrib>KIM, Haneul</creatorcontrib><creatorcontrib>LEE, Suin</creatorcontrib><title>Chimeric antigen receptor specifically binding to CD 300c antigen or receptor thereof</title><description>The present invention relates to a chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof, and immune cells expressing same, or the like. The chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof according to the present invention specifically recognizes cancer cells expressing a CD300c antigen or CD300c receptor and directly effectively inhibits the growth of cancer, metastasis, or the like, and moreover, activates T cells and the like in the body through the inhibition of CD300c, and thereby can reduce side effects and also increase a cancer therapeutic effect, and thus is expected to be effectively used as an immunotherapeutic agent for various cancers.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7EKwjAURuEsDqK-w4XOQkwE6Vii4gPYucT4t70Qk5Bk8e11EF2dzvKdpejNzA9kdmRD5QmBMhxSjZlKguORnfX-STcOdw4T1UjmSFrK3_Cm36fOyIjjWixG6ws2n65Ecz5dzWWLFAeUZB0C6tD1Siqp2706tN1O_6deWLM5MQ</recordid><startdate>20220616</startdate><enddate>20220616</enddate><creator>JEON, Jaewon</creator><creator>KIM, Haneul</creator><creator>LEE, Suin</creator><scope>EVB</scope></search><sort><creationdate>20220616</creationdate><title>Chimeric antigen receptor specifically binding to CD 300c antigen or receptor thereof</title><author>JEON, Jaewon ; KIM, Haneul ; LEE, Suin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020394279A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JEON, Jaewon</creatorcontrib><creatorcontrib>KIM, Haneul</creatorcontrib><creatorcontrib>LEE, Suin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JEON, Jaewon</au><au>KIM, Haneul</au><au>LEE, Suin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chimeric antigen receptor specifically binding to CD 300c antigen or receptor thereof</title><date>2022-06-16</date><risdate>2022</risdate><abstract>The present invention relates to a chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof, and immune cells expressing same, or the like. The chimeric antigen receptor specifically binding to a CD300c antigen or a receptor thereof according to the present invention specifically recognizes cancer cells expressing a CD300c antigen or CD300c receptor and directly effectively inhibits the growth of cancer, metastasis, or the like, and moreover, activates T cells and the like in the body through the inhibition of CD300c, and thereby can reduce side effects and also increase a cancer therapeutic effect, and thus is expected to be effectively used as an immunotherapeutic agent for various cancers.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2020394279A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | Chimeric antigen receptor specifically binding to CD 300c antigen or receptor thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A07%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JEON,%20Jaewon&rft.date=2022-06-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020394279A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |